Detection of urinary HE4 as a biomarker for epithelial ovarian cancer

被引：2
|
作者：
Li, Zhong-Qian [1 ]
Radwan, Rachel [1 ]
Polkowski, Julie [1 ]
Raju, Savitha [1 ]
Falcone, Katherine [1 ]
Simamora, Rebecca [1 ]
Kettlety, Timothy [1 ]
Moore, Richard G. [2 ]
Barnes, Grady [1 ]
机构：
[1] Fujirebio Diagnost Inc, Malvern, PA USA
[2] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-LB-451
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-451
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis
    Li, Y.
    Wang, Z. -C
    Luo, L.
    Mu, C. -Y.
    Xu, J.
    Feng, Q.
    Li, S. -B.
    Gu, B.
    Ma, P.
    Lan, T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 604 - 610
  • [32] HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer
    Karlsen, Mona Aarenstrup
    Hogdall, Claus
    Nedergaard, Lotte
    Prahm, Kira Philipsen
    Karlsen, Nikoline Marie Schou
    Ekmann-Gade, Anne Weng
    Schnack, Tine Henrichsen
    Poulsen, Tim Svenstrup
    Christensen, Ib Jarle
    Hogdall, Estrid
    APMIS, 2016, 124 (12) : 1038 - 1045
  • [33] The diagnostic, prediction of postoperative recurrence and prognostic value of HE4 in epithelial ovarian cancer
    Chen, Longyi
    Yang, Xiuwei
    Abasi, Xiariwana
    Shapaer, Gulinaer
    Aizimu, Ayinuer
    Zhang, Shuping
    Wan, Yingxiang
    Kamaer, Xiamuxi
    Tuerxun, Tuoluniayi
    Abula, Reyihanguli
    Zhang, Qingyue
    JOURNAL OF BUON, 2018, 23 (02): : 428 - 432
  • [34] PERFORMANCE OF ARCHITECT HE4 IN MONITORING PATIENTS WITH EPITHELIAL OVARIAN CANCER AND ESTIMATING RISK OF EPITHELIAL OVARIAN CANCER IN WOMEN WITH AN ADNEXAL MASS
    Kettlety, T.
    Radwan, R.
    Vasko, A.
    Burkhart, B.
    Glover, C.
    Zhu, L.
    Acon, B.
    Young, J.
    Polkowski, J.
    Falcone, K.
    Raju, S.
    Li, Z.
    Dickson, D.
    Simamora, R.
    Barnes, G.
    Nilsson, O.
    TUMOR BIOLOGY, 2010, 31 : S110 - S110
  • [35] HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection
    Fritz-Rdzanek, Anna
    Grzybowski, Wojciech
    Beta, Jaroslaw
    Durczynski, Andrzej
    Jakimiuk, Artur
    ONCOLOGY LETTERS, 2012, 4 (03) : 385 - 389
  • [36] HE4-A novel biomarker for monitoring patients with Epithelial Ovarian Cancer
    Nilsson, O.
    Allard, J. W.
    Moore, R. G.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A113 - A113
  • [37] Serum HE4 as a Useful Biomarker in Discriminating Ovarian Cancer From Benign Pelvic Disease
    Zheng, Hong
    Gao, Yunong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (06) : 1000 - 1005
  • [38] The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma
    Hellström, I
    Raycraft, J
    Hayden-Ledbetter, M
    Ledbetter, JA
    Schummer, M
    McIntosh, M
    Drescher, C
    Urban, N
    Hellström, KE
    CANCER RESEARCH, 2003, 63 (13) : 3695 - 3700
  • [39] Ovarian-Cancer Biomarker (HE4) Recognition in Serum Using Hetero TFET Biosensor
    Bhattacharyya, Amit
    De, Debashis
    Chanda, Manash
    IEEE TRANSACTIONS ON NANOTECHNOLOGY, 2023, 22 : 238 - 244
  • [40] Diagnostic and Prognostic Potential of HE4 in Ovarian Cancer
    Langhe, R.
    O'Toole, S.
    Norris, L.
    Petzold, M.
    Harrison, A.
    Varley, R.
    Abusaadeh, F.
    Gleeson, N.
    O'Leary, J.
    MODERN PATHOLOGY, 2013, 26 : 284A - 284A
12345